Mélatonine 3 mg
Natural health product licensed in Canada
- Licence holder
- BioPharma Ltée
- NPN or DIN-HM
- 80052296
- Status
- Active licence
- Licence date
- 8 July 2014
- Revision date
- Not provided
- Form
- Capsule, enrobage gélatine
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| N-acétyl-5-méthoxytryptamine Source : Mélatonine | 3 milligramme | Not calculated |
Non-medicinal ingredients
Gélatine, Stéarate de magnésium, Cellulose - microcrystalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 1 Capsule ; maximum: 3 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Aide à augmenter la durée totale du sommeil (aspect de la qualité du sommeil) chez les personnes souffrant de restriction du sommeil ou d`horaire altéré du sommeil, par exemple le travail à horaires variables et le décalage horaire. Aide à prévenir et/ou réduire les effets du décalage horaire (p.ex. fatigue diurne, sommeil perturbé) pour les personnes voyageant en avion vers l'èst et traversant deux fuseaux horaires ou plus. Aide à réduire le temps nécessaire pour s'endormir (aspect délai d'endormissement de la qualité du sommeil) chez les personnes souffrant du syndrome de retard de phase du sommeil. Aide à rebalancer les cycles veille-sommeil (aspect du rythme circadien)
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80052296
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.